The option triggered a $10 million milestone payment to Recursion, bringing total upfront and milestone payments received from Sanofi under the collaboration to $144 million; Recursion is eligible for ...
Leading Healthcare Investors, including Janus Henderson Investors, Invus, Longaeva Partners, ARK Invest, Driehaus Capital Management and other ...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announced results from Late-Breaking Clinical ...
Development of an Interactive Generative AI Service for Assignments- A New Educational System for Completing School Homework ...
AresONE Plus 1600GE for testing high-density switching: Packs eight OSFP1600 ports into a single 2U chassis, delivering 12.8T of line-rate traffic at 64 bytes. It supports 1600GE PAM4 signaling over ...
Riyadh airport. 1 killed, 11 injured in attack on Riyadh airport. In a follow-up statement on the attack on King Khalid ...
What were the most important current affairs for UPSC this week? From the 2026 Nobel Prizes and Global Innovation Index to ...
Good morning, this is Masaki.French company Mistral AI announced on the 6th that it will release a new 1 trillion-parameter class model, including its internal weights, by the end of October. The name ...
Boehringer Ingelheim reported positive Phase III SYNCHRONIZE-2 results for investigational survodutide (BI 456906) in adults living with obesity or overweight and type 2 diabetes.
A flash flood warning has been issued for parts of Dallas County, according to the National Weather Service's Office in Fort ...
The monthly inflation in Kazakhstan in September 2026 remained at August's level — 0.6%, Qazinform News Agency learned from ...
About 11% of Americans are taking a GLP-1 medication, up considerably from 3% in 2024, according to a recent Gallup poll. These medications can be powerful tools to help patients reach a range of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results